Development of a validated stability-indicating LC method for nitazoxanide in pharmaceutical formulations

Chromatographia

Volumn 67, Issue 1-2, 2008, Pages 131-136

  Malesuik, Marcelo Donadel ^a   Cardoso, Simone Gonçalves ^b   Steppe, Martin ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Column liquid chromatography; Nitazoxanide; Stability indicating method; Validation

Indexed keywords

ACETONITRILE; EXCIPIENT; NITAZOXANIDE; NIXORAN; PHOSPHORIC ACID; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); DRUG DEGRADATION; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG STABILITY; LIQUID CHROMATOGRAPHY; PARTICLE SIZE; POWDER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; SUSPENSION; TABLET; VALIDATION PROCESS;

EID: 38049005535     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-007-0454-9     Document Type: Article

References (15)

1. White C (2004) Expert Rev Anti Infect Ther 2:43-50
2. Fox LM, Saravolatz LD (2005) Clin Infect Dis 40:1173-1180
3. Raether W, Hänel H (2003) Parasitol Res 90:S19-S39
4. Stockis A, Deroubaix X, Lins R, Jeanbaptiste B, Calderon P, Rossignol JF (1996) Int J Clin Pharmacol Ther 34:349-351
5. Broekhuysen J, Stockis A, Lins RL, De Graeve J, Rossignol JF (2000) Int J Clin Pharmacol Ther 38:387-394
6. Kapse GK, Prabhakar G, Raju SA (2006) Indian J Pharm Sci 68:403-406
7. Gopu CL, Thomas S, Paradkar AR, Mahadik KR (2007) J Sci Ind Res 66:141-145
8. ICH (2005) In: International conference on harmonization of technical requirements for registration of pharmaceuticals for human use, Validation of analytical procedures: Text and Methodology Q2(R1), Switzerland
9. The United States Pharmacopoeia 30th (2007) Rockville, MD
10. Bakshi M, Singh S (2002) J Pharm Biomed Anal 28:1011-1040
11. ICH (2003) In: International conference on harmonization of technical requirements for registration of pharmaceuticals for human use, Stability testing of new drug substance and products Q1A(R2), Switzerland
12. Breier AR, Steppe M, Schapoval EES (2006) Chromatographia 64:725-729
13. Snyder LR, Kirkland JJ, Glajch JL (1997) Practical HPLC method development and validation, 2nd edn. Wiley, New York, p 765
14. Lindsay S (1992) High performance liquid chromatography, 2nd edn. Wiley, New York, p 337
15. FDA (1994) Center of Drug Evaluation and Research. Reviewer guidance: validation of chromatographic methods, Rockville, MD